About

Jorge Olden, MD, followed a path to medicine because he enjoyed science and helping people. With a background in mathematics and an interest in anatomy and physiology, radiology seemed like a good fit. Dr. Olden graduated with a medical degree from Stony Brook Health Sciences Center and began his internship year at Long Island Jewish Medical Center. He started his Diagnostic Residency Training at Tufts Medical Center and completed it at Duke University Medical Center before moving on to a Nuclear Medicine Fellowship at Cleveland Clinic Foundation.

His expertise is in molecular imaging, specifically using radiotracers to diagnose disease, also known as nuclear medicine. He works closely with other healthcare professionals to ensure patients receive accurate diagnoses and effective treatment plans. As a healthcare professional, Dr. Olden is committed to ongoing education and training to stay up-to-date on the latest advancements in his field. He’s also passionate about collaborating with other healthcare professionals to provide the best possible care for patients.

While he’s done research on a variety of topics and is particularly interested in quantification and extraction of more information from existing data (for example, studying whether tumors show uptake of tracers injected for other reasons or the frequency of incidentally detected tumors), his research currently focuses on the use of hormonal agonists (specifically estrogen and progesterone) to study endometriosis and endometrial cancer. This will allow physicians to detect endometriosis better than MRI alone, possibly decreasing the number of invasive procedures and better determining who can benefit from hormonally-targeted therapies.

Expertise

Molecular imaging, specifically using radiotracers to diagnose disease, also known as nuclear medicine.

Research

• The use of hormonal agonists (specifically estrogen and progesterone) to study endometriosis and endometrial cancer
• Quantification and extraction of more information from existing data
  • For example, studying whether tumors show uptake of tracers injected for other reasons or the frequency of incidentally detected tumors), his research currently focuses on hormonal agonists, specifically estrogen and progesterone.